Viatris (VTRS) Intangibles (2019 - 2026)
Viatris (VTRS) posted Intangibles of $13.7 billion for Q2 2026, down 5.56% on a QoQ basis from $14.5 billion in Q1 2026, and down 16.21% year-over-year from $16.3 billion in Q2 2025.
Analysis
Viatris (VTRS) Intangibles (2019 - 2026) Analysis & Trends
Viatris has reported Intangibles for 8 years, with the latest figure at $13.7 billion in Q2 2026.
- On a quarterly basis, Intangibles fell 16.21% year-over-year to $13.7 billion in Q2 2026; TTM through Jun 2026 was $13.7 billion, a 16.21% decrease from a year earlier, with the FY2025 full-year figure at $15.1 billion, down 11.53% from the prior year.
- Intangibles was $13.7 billion for Q2 2026 at Viatris, down from $14.5 billion in the prior quarter.
- The five-year high for Intangibles was $25.3 billion in Q1 2022, with the low at $13.7 billion in Q2 2026.
- Average Intangibles over 5 years is $19.2 billion, with a median of $18.8 billion recorded in 2024.
- The sharpest annual moves came in 2023 and 2024: Intangibles fell 7.53% in 2023, then declined 16.6% in 2024.
- Over 5 years, Intangibles stood at $22.6 billion in 2022, then dropped by 15.15% to $19.2 billion in 2023, then slipped by 11.0% to $17.1 billion in 2024, then retreated by 11.53% to $15.1 billion in 2025, then slipped by 9.44% to $13.7 billion in 2026.
- The last three Intangibles figures came in at $13.7 billion (Q2 2026), $14.5 billion (Q1 2026), and $15.1 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | 3.45 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | 13.68 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 1.09 Bn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 587.83 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 4.18 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | 142.48 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 449.86 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 29.23 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | 5.29 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.68 Bn |
| Mar 31, 2026 | 14.48 Bn |
| Dec 31, 2025 | 15.10 Bn |
| Sep 30, 2025 | 15.72 Bn |
| Jun 30, 2025 | 16.32 Bn |
| Mar 31, 2025 | 16.66 Bn |
| Dec 31, 2024 | 17.07 Bn |
| Sep 30, 2024 | 17.98 Bn |
| Jun 30, 2024 | 18.42 Bn |
| Mar 31, 2024 | 19.13 Bn |
| Dec 31, 2023 | 19.18 Bn |
| Sep 30, 2023 | 21.28 Bn |
| Jun 30, 2023 | 22.08 Bn |
| Mar 31, 2023 | 22.70 Bn |
| Dec 31, 2022 | 22.61 Bn |
| Sep 30, 2022 | 23.01 Bn |
| Jun 30, 2022 | 24.10 Bn |
| Mar 31, 2022 | 25.25 Bn |
| Dec 31, 2021 | 26.13 Bn |
| Sep 30, 2021 | 26.99 Bn |